共 50 条
- [4] COMBINATION INTRAPERITONEAL (IP) CHEMOTHERAPY OF REFRACTORY RECURRENT OVARIAN-CARCINOMA (ROC) EMPLOYING A REGIMEN OF CISPLATIN (C) AND ETOPOSIDE (E) - A PHASE-2 TRIAL CLINICAL RESEARCH, 1988, 36 (03): : A497 - A497
- [5] INTRAPERITONEAL CISPLATIN AND REGIONAL HYPERTHERMIA FOR OVARIAN-CARCINOMA INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (05): : 1245 - 1251
- [8] COMBINATION CISPLATIN-BASED INTRAPERITONEAL CHEMOTHERAPY FOR REFRACTORY OVARIAN-CARCINOMA - IMPACT ON SURVIVAL CLINICAL RESEARCH, 1986, 34 (03): : A882 - A882
- [10] PHARMACOKINETICS OF IP CISPLATIN IN REFRACTORY OVARIAN-CARCINOMA CANCER TREATMENT REPORTS, 1983, 67 (12): : 1085 - 1092